You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Multitargeted Antifolate

Showing 1 - 25 of 58
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Urothelial Carcinoma, Metastatic Cancer Trial in Houston (Pemetrexed, Zimberelimab, Etrumadenant)

Not yet recruiting
  • Urothelial Carcinoma
  • Metastatic Cancer
  • Houston, Texas
    MD Anderson Cancer Center
Nov 28, 2022

Lung Cancer Trial in Houston (AMG 510, Cisplatin, Carboplatin)

Recruiting
  • Lung Cancer
  • AMG 510
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 10, 2022

Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Tampa

Recruiting
  • Lung Non-Small Cell Carcinoma
  • +4 more
  • Tampa, Florida
    Moffitt Cancer Center
Aug 16, 2022

Advanced Cancers Trial in Houston (Crizotinib (Xalkori), Pazopanib, Pemetrexed)

Terminated
  • Advanced Cancers
  • Crizotinib (Xalkori)
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 3, 2021

Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant, Infiltrating Bladder Urothelial Carcinoma With Glandular

Recruiting
  • Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 17, 2021

Advanced Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IIIC Lung Cancer AJCC v8 Trial (drug, procedure,

Not yet recruiting
  • Advanced Lung Non-Small Cell Carcinoma
  • +3 more
  • (no location specified)
Oct 21, 2023

Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Nashville (procedure, drug, other, biological, radiation)

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer AJCC v8
  • Biospecimen Collection
  • +9 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Aug 11, 2022

Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8 Trial (Carboplatin, Durvalumab,

Withdrawn
  • Lung Non-Small Cell Carcinoma
  • +4 more
  • (no location specified)
Oct 26, 2021

Stage I Lung Non-Small Cell Cancer AJCC v7, Stage IA Lung Non-Small Cell Carcinoma AJCC v7, Stage IB Lung Non-Small Cell

Active, not recruiting
  • Stage I Lung Non-Small Cell Cancer AJCC v7
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 24, 2022

Locally Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8 Trial in Seattle

Recruiting
  • Locally Advanced Lung Non-Small Cell Carcinoma
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Apr 13, 2022

Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8, Stage III Lung Cancer AJCC v8 Trial (drug,

Not yet recruiting
  • Locally Advanced Lung Non-Small Cell Carcinoma
  • +2 more
  • (no location specified)
Nov 14, 2022

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIC Lung Cancer AJCC v8 Trial in

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +5 more
  • Bevacizumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 13, 2022

Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in San Francisco (drug,

Withdrawn
  • Lung Non-Small Cell Carcinoma
  • +9 more
  • San Francisco, California
    University of California, San Francisco
Feb 17, 2022

Rectal Cancer Trial in Göteborg ([6R] 5,10-methylenetetrahydrofolate (arfolitixorin), Pemetrexed)

Completed
  • Rectal Cancer
  • [6R] 5,10-methylenetetrahydrofolate (arfolitixorin)
  • Pemetrexed
  • Göteborg, Sweden
    Sahlgrenska University Hospital
Sep 7, 2020

Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage III

Terminated
  • Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma
  • +9 more
  • Bintrafusp Alfa
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 4, 2022

Stage III Lung Cancer AJCC v8, Stage III Lung Non-Small Cell Cancer AJCC v7, Stage IIIA Lung Cancer AJCC v8 Trial in Houston

Not yet recruiting
  • Stage III Lung Cancer AJCC v8
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
May 14, 2021

Peritoneal Malignant Mesothelioma Trial in United States (biological, drug, procedure)

Recruiting
  • Peritoneal Malignant Mesothelioma
  • Atezolizumab
  • +8 more
  • Phoenix, Arizona
  • +25 more
Feb 2, 2023

Advanced Malignant Solid Tumor, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +28 more
  • Conroe, Texas
  • +4 more
Dec 5, 2022

Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8 Trial in United States (biological,

Recruiting
  • Lung Non-Small Cell Carcinoma
  • +3 more
  • Atezolizumab
  • +7 more
  • Jonesboro, Arkansas
  • +35 more
Aug 12, 2022

Advanced Lung Adenocarcinoma, Advanced Lung Adenosquamous Carcinoma, Advanced Lung Non-Small Cell Carcinoma Trial in United

Recruiting
  • Advanced Lung Adenocarcinoma
  • +10 more
  • Phoenix, Arizona
  • +98 more
Feb 2, 2023

Lung Cancer Trial in Houston (Carboplatin, Pemetrexed, Bevacizumab)

Completed
Has Results
  • Lung Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 13, 2019

NSCLC, EGF-R Positive NSCLC Trial in Shenyang (Icotinib, Cisplatin, Carboplatin)

Not yet recruiting
  • NSCLC
  • EGF-R Positive Non-Small Cell Lung Cancer
  • Shenyang, Liaoning, China
    Liaoning Cancer Hospital & Institute
Nov 28, 2021

Sarcoma Trial in Seoul (Pemetrexed, cisplatin)

Active, not recruiting
  • Sarcoma
  • Pemetrexed, cisplatin
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System
May 30, 2022

Leptomeningeal Metastasis Trial in Changchun (Pemetrexed, Dexamethasone, Radiotherapy)

Completed
  • Leptomeningeal Metastasis
  • Changchun, Jilin, China
    The First Hospital of Jilin University
Dec 23, 2019

Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2 Trial in Worldwide (Gilteritinib, Midostaurin)

Suspended
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome With Excess Blasts-2
  • Adelaide, Australia
  • +193 more
Jan 5, 2023